Home  |  About us  |  Editorial board  |  Ahead of print  | Current issue  |  Archives  |  Submit article  |  Instructions |  Search  |   Subscribe  |  Advertise  |  Contacts  |  Login 
  Users Online: 145Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
This article has been cited by
1Taking the 'Risk' out of risk-based monitoring
Ashwaria Gupta
Perspectives in Clinical Research.2013;4(4)193
[DOI]
2Data-driven risk identification in phase III clinical trials using central statistical monitoring
Catherine Timmermans,David Venet,Tomasz Burzykowski
International Journal of Clinical Oncology.2016;21(1)38
[DOI]
3Time-consuming and expensive data quality monitoring procedures persist in clinical trials: A national survey
Lauren Houston,Allison Martin,Ping Yu,Yasmine Probst
Contemporary Clinical Trials.2021;103(1)106290
[DOI]
4Self-audits as alternatives to travel-audits for improving data quality in the Caribbean, Central and South America network for HIV epidemiology
Sarah C. Lotspeich,Mark J. Giganti,Marcelle Maia,Renalice Vieira,Daisy Maria Machado,Regina Célia Succi,Sayonara Ribeiro,Mario Sergio Pereira,Maria Fernanda Rodriguez,Gaetane Julmiste,Marco Tulio Luque,Yanink Caro-Vega,Fernando Mejia,Bryan E. Shepherd,Catherine C. McGowan,Stephany N. Duda
Journal of Clinical and Translational Science.2020;4(2)125
[DOI]
5A Data-Driven Approach to Risk-Based Source Data Verification
Elizabeth Nielsen,DeAnn Hyder,Chao Deng
Therapeutic Innovation & Regulatory Science.2014;48(2)173
[DOI]
6Key Considerations in the Transition to Risk-Based Monitoring
Michael J. Rosenberg
Therapeutic Innovation & Regulatory Science.2014;48(4)428
[DOI]
7Evolving quality standards for large-scale registries: the GARFIELD-AF experience
Keith A.A. Fox,Bernard J. Gersh,Sory Traore,A. John Camm,Gloria Kayani,Anders Krogh,Shweta Shweta,Ajay K. Kakkar
European Heart Journal - Quality of Care and Clinical Outcomes.2016;48(4)qcw058
[DOI]
8Investigation of the Factors Affecting Risk-Based Quality Management of Investigator-Initiated Investigational New-Drug Trials for Unapproved Anticancer Drugs in Japan
Tomohisa Sudo,Akihiro Sato
Therapeutic Innovation & Regulatory Science.2017;51(5)589
[DOI]
9Clinical trial monitoring effectiveness: Remote risk-based monitoring versus on-site monitoring with 100% source data verification
Osamu Yamada,Shih-Wei Chiu,Munenori Takata,Michiaki Abe,Mutsumi Shoji,Eri Kyotani,Chiyo Endo,Minami Shimada,Yuko Tamura,Takuhiro Yamaguchi
Clinical Trials.2021;18(2)158
[DOI]
10Heterogeneity in clinical research data quality monitoring: A national survey
Lauren Houston,Ping Yu,Allison Martin,Yasmine Probst
Journal of Biomedical Informatics.2020;108(2)103491
[DOI]
11Evaluating Source Data Verification as a Quality Control Measure in Clinical Trials
Nicole Sheetz,Brett Wilson,Joanne Benedict,Esther Huffman,Andy Lawton,Mark Travers,Patrick Nadolny,Stephen Young,Kyle Given,Lawrence Florin
Therapeutic Innovation & Regulatory Science.2014;48(6)671
[DOI]
12Efficient Source Data Verification Using Statistical Acceptance Sampling: A Simulation Study
Rutger M. van den Bor,Bas J. Oosterman,Martinus B. Oostendorp,Diederick E. Grobbee,Kit C. B. Roes
Therapeutic Innovation & Regulatory Science.2016;50(1)82
[DOI]
13The impact of clinical trial monitoring approaches on data integrity and cost—a review of current literature
Rasmus Olsen,Asger Reinstrup Bihlet,Faidra Kalakou,Jeppe Ragnar Andersen
European Journal of Clinical Pharmacology.2016;72(4)399
[DOI]
14Implementing an automated monitoring process in a digital, longitudinal observational cohort study
Lisa Lindner,Anja Weiß,Andreas Reich,Siegfried Kindler,Frank Behrens,Jürgen Braun,Joachim Listing,Georg Schett,Joachim Sieper,Anja Strangfeld,Anne C. Regierer
Arthritis Research & Therapy.2021;23(1)399
[DOI]
  Feedback 
  Subscribe 

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal